TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) is a publicly traded company in the Unknown sector. Across all available filings, 39 corporate insiders have executed 617 transactions totaling $82.4M, demonstrating a bearish sentiment with -$49.4M in net insider flow. The most recent transaction on Dec 16, 2025 involved a sale of 77,400 shares valued at $2.3M.
No significant insider buying has been recorded for TEVA in the recent period.
No significant insider selling has been recorded for TEVA in the recent period.
Based on recent SEC filings, insider sentiment for TEVA is bearish with an Insider Alignment Score of 20/100 and a net flow of -$49.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 39 insiders are actively trading TEVA stock, having executed 617 transactions in the past 90 days. The most active insider is Roberto Mignone (Executive), who has made 13 transactions totaling $31.7M.
Get notified when executives and directors at TEVA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Mignone Roberto | Executive | Sale | 77,400 | $30.24 | $2.3M | Large |
| Dec 16, 2025 | Weiss Amir | Executive | Sale | 12,300 | $30.20 | $371.5K | |
| Dec 9, 2025 | Sabag Mark | Executive | Option Exercise | 118,724 | $18.61 | $2.2M | Large |
| Dec 9, 2025 | Sabag Mark | Executive | Sale | 118,724 | $28.75 | $3.4M | Large |
| Dec 9, 2025 | Sabag Mark | Executive | Sale | 98,168 | $28.70 | $2.8M | Large |
| Dec 9, 2025 | Daniell Richard | Executive | Sale | 115,468 | $28.68 | $3.3M | Large |
| Dec 9, 2025 | Daniell Richard | Executive | Option Exercise | 15,011 | $16.99 | $255.0K | |
| Dec 9, 2025 | Daniell Richard | Executive | Option Exercise | 100,457 | $18.61 | $1.9M | Large |
| Dec 2, 2025 | Lichtenstein Chen | Executive | Option Exercise | 4,804 | $N/A | $0 | |
| Nov 26, 2025 | Mignone Roberto | Executive | Sale | 50,000 | $26.03 | $1.3M | Large |
| Nov 20, 2025 | Fox Christine | Executive | Option Exercise | 63,492 | $N/A | $0 | |
| Nov 20, 2025 | Fox Christine | Executive | Sale | 28,229 | $24.78 | $699.5K | Large |
| Nov 14, 2025 | Fox Christine | Executive | Sale | 30,000 | $25.11 | $753.3K | Large |
| Nov 6, 2025 | Weiss Amir | Executive | Sale | 12,300 | $24.44 | $300.6K | |
| Nov 6, 2025 | Mignone Roberto | Executive | Sale | 200,000 | $24.11 | $4.8M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 229 | $65.9M | 75.5% |
Purchase(P) | 6 | $16.5M | 18.9% |
Exercise(M) | 358 | $4.3M | 5.0% |
Expiration(H) | 1 | $492.5K | 0.6% |
Payment(F) | 8 | $101.8K | 0.1% |
Small Acquisition(L) | 1 | $151 | 0.0% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Award(A) | 13 | $0 | 0.0% |
Insider selling pressure at TEVA PHARMACEUTICAL INDUSTRIES LTD has increased, with 39 insiders executing 617 transactions across all time. Total sales of $65.9M significantly outpace purchases of $16.5M, resulting in a net outflow of $49.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.